MiNK Therapeutics, Inc. entered into a stock purchase agreement for issuance of 4,640,000 common shares at a price of $1.25 per share for gross proceeds of $5,800,000 on May 13, 2024. The transaction is expected to close on May 14, 2024, subject to customary closing conditions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.98 USD | +1.16% | -0.51% | -8.41% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.41% | 38.12M | |
+52.36% | 56.69B | |
-3.86% | 41B | |
+38.14% | 38.11B | |
-12.01% | 26.89B | |
+14.13% | 25.59B | |
-21.62% | 18.59B | |
+0.21% | 12.39B | |
+25.96% | 11.99B | |
+23.02% | 11.88B |
- Stock Market
- Equities
- INKT Stock
- News MiNK Therapeutics, Inc.
- MiNK Therapeutics, Inc. announced that it expects to receive $5.8 million in funding